{
    "data": [
        {
            "title": "Nifty seen clearing first roadblock; next stop at 23,800? Key levels here",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div>The NSE Nifty 50 index has surged over 1 per cent in intra-day deals on Tuesday, and is now seen quoting above its super trend line on the daily scale for the first time since December 19, 2024. A close above 23,604, shall qualify as a positive breakout for the Nifty on the daily scale.<small class=\"brtagPara\"> </small> At the high point of the day so far, at 23,659, the Nifty gained 3.8 per cent from its recent low of 22,787. That apart, the Nifty 50 is seen quoting above its 20-DMA (Daily Moving Average) for the fourth straight trading session.<small class=\"brtagPara\"> </small> Technically, the Nifty is now seen clearing its first key hurdle as the index attempts a pullback from its record high of 26,277. The Nifty 50 had shed 13.3 per cent or almost 3,500 points from the peak in the last four months.<small class=\"brtagPara\"> </small> Amid the attempted recovery, the Nifty can potentially attempt a rebound towards 24,250 levels. The next key hurdle for the Nifty is placed around 23,780 levels, above which resistance can be expected around 24,020 and 24,150 levels. CLICK HERE FOR THE CHART<small class=\"brtagPara\"> </small> <strong>ALSO READ: <a href=\"https://www.business-standard.com/markets/news/nifty-may-target-24-300-post-budget-trump-tariff-rbi-policy-key-triggers-125020101053_1.html?1738656589\" target=\"_blank\">Nifty may target 24,300 post Budget; Trump tariff, RBI policy key triggers</a></strong><small class=\"brtagPara\"> </small> The near-term bias for the Nifty is likely to remain upbeat as long as the index holds above 23,500 levels; below which the key support for the index stands at the 20-DMA (Daily Moving Average) at 23,250.<small class=\"brtagPara\"> </small> The BSE Sensex, meanwhile, is seen quoting around 78,150 levels. The BSE benchmark has gained nearly 2,900 points from its recent low at 75,267.<small class=\"brtagPara\"> </small> The quarterly Fibonacci chart suggests that sustained trade above 78,150, shall pave the way for a likely rally towards 80,000-mark, above which a test of 81,150 seems likely. Interim resistance for the Sensex can be expected around 78,635 and 79,335 levels.  In case of a dip, the BSE Sensex may seek support around 77,500 levels.<small class=\"brtagPara\"> </small><br/></div>",
            "pub_date": "2025-02-04 16:25:28",
            "link": "https://www.business-standard.com/markets/news/nifty-seen-clearing-first-roadblock-next-stop-at-23-800-key-levels-here-125020400643_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400643"
        },
        {
            "title": "Will injured Rajasthan captain Samson be available for start of IPL 2025?",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_7-0\" style=\"min-height:250px\"></div><div>\r\n\tThe misery of India’s wicketkeeper-batter Sanju Samson does not seem to be ending anytime soon. After struggling with the bat during the T20 series against England, he is now likely to be away from cricketing action for five to six weeks after picking up a fracture in his index finger during the fifth T20 International against England in Mumbai on Sunday.<small class=\"brtagPara\"> </small> Samson received a nasty blow from English pacer—and his Rajasthan Royals teammate—Jofra Archer’s delivery but was able to continue playing after some medical attention. His presence on the field made fans believe the blow was not of a serious nature.<small class=\"brtagPara\"> </small> However, the latest media reports suggest otherwise.<small class=\"brtagPara\"> </small> <a href=\"https://www.business-standard.com/cricket/champions-trophy/schedule\" target=\"_blank\"><strong>Check ICC Champions Trophy 2025 full schedule, match timings (IST) here</strong></a></div><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_8-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\n<strong>Ruled out of Ranji Trophy quarterfinals</strong><small class=\"brtag\"> </small></div>\n<div>\r\n\tSamson has already returned to Thiruvananthapuram and will undergo rehabilitation at the National Cricket Academy (NCA) before resuming training. According to reports, Samson’s injury would require at least five to six weeks of recovery before he could resume proper net sessions. Given this timeline, he would be unavailable for Kerala’s Ranji Trophy quarterfinal against J&amp;K in Pune from February 8-12.</div>\n<small class=\"brtag\"> </small>\n<div>\n<strong>Return in IPL 2025?</strong><small class=\"brtag\"> </small></div>\n<div>\r\n\tSamson’s comeback would most likely happen during the IPL, where he will once again captain Rajasthan Royals in IPL 2025.<small class=\"brtagPara\"> </small> The reports further revealed that his return to competitive cricket would depend on clearance from the NCA after completing rehabilitation, and if the timeline extends beyond initial estimates, he could also miss the early stages of IPL 2025.<small class=\"brtagPara\"> </small>\n<div>\n<strong class=\"read_more\">ALSO READ: <a href=\"/cricket/news/india-vs-england-odis-full-list-of-series-results-for-ind-vs-eng-125020400424_1.html\" target=\"_blank\">India vs England ODIs: Full list of series results for IND vs ENG</a></strong></div></div><div id=\"between_article_content_9-0\" style=\"min-height:250px\"></div><div class=\"mb-20\"><div class=\"latestnews_stryalsoread__HlMna\"></div></div>\n<small class=\"brtag\"> </small> <small class=\"brtagPara\"> </small>\n<div>\n<strong>The injury incident</strong><small class=\"brtag\"> </small></div>\n<div>\r\n\tSamson, who endured a disappointing series against England, sustained the injury when a third delivery from Archer, bowled at nearly 150 kmph, struck his right index finger. Despite the painful blow, he managed to hit a six and a four but later experienced severe swelling in the dugout. Medical scans later confirmed the fracture.</div>\n<small class=\"brtag\"> </small>\n<div>\n<strong>Underwhelming series</strong><small class=\"brtag\"> </small></div>\n<div>\r\n\tAfter a spectacular run against Bangladesh and South Africa, where he smashed three centuries in seven games, Samson struggled in the England series, managing just 51 runs in five matches. His highest score was 26 in the opening match at Eden Gardens.</div><div id=\"between_article_content_10-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThe Rajasthan Royals skipper faced repeated difficulties against short-pitched deliveries from Archer, Mark Wood, and Saqib Mahmood, often losing his wicket early during the Powerplay.<small class=\"brtagPara\"> </small>\n<strong>Ashwin on Samson's struggle</strong><small class=\"brtagPara\"> </small>\r\n\tFormer India spinner R Ashwin expressed concern over Sanju Samson’s form, stating that if the batter continues to struggle, his mind may begin to play tricks, leading to self-doubt and difficulty adapting. Ashwin also advised Suryakumar Yadav, who is also out of form, to adjust his approach. He mentioned that while form slumps can happen in one or two games, when a batter is being attacked in a specific way, a different approach should be adopted to counter it.<small class=\"brtagPara\"> </small>\n<small class=\"brtagPara\"> </small>\n<small class=\"brtagPara\"> </small>\n<small class=\"brtagPara\"> </small> <a href=\"https://www.business-standard.com/cricket/champions-trophy\" target=\"_blank\"><strong>Check latest news on ICC Champions Trophy 2025 here</strong></a><small class=\"brtag\"> </small>\n<small class=\"brtagPara\"> </small>\n<div>\n<a href=\"https://www.business-standard.com/cricket/champions-trophy/points-table\" target=\"_blank\"><strong>Check ICC Champions Trophy 2025 points table here</strong></a></div></div><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div>\n<a href=\"https://www.business-standard.com/cricket/champions-trophy/points-table\" target=\"_blank\"><small class=\"brtag\"> </small></a>\n<small class=\"brtag\"> </small></div>",
            "pub_date": "2025-02-04 16:25:28",
            "link": "https://www.business-standard.com/cricket/ipl/will-injured-rajasthan-captain-samson-be-available-for-start-of-ipl-2025-125020400446_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400446"
        },
        {
            "title": "RBI seen cutting rates for first time since May 2020, suggests poll",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><p>\r\n\tIndia's central bank is widely expected to cut interest rates for the first time in nearly five years in Governor Sanjay Malhotra's first monetary policy review on Friday, aiming to boost economic growth which is seen falling to a four-year low.</p>\n<p>\r\n\tOver 70 per cent of respondents, 45 of 62, in a Jan. 22-30 Reuters poll forecast the RBI would cut its key repo rate by 25 basis points to 6.25 per cet at the conclusion of its Feb. 5-7 meeting, while others expect it will keep rates unchanged, mostly because of above-target inflation.</p>\n<p>\r\n\tThe monetary policy review follows closely on the heels of the federal budget, where the government slashed personal tax rates to boost spending and spur growth.</p><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<p>\r\n\t\"With the finance ministry still keeping the overall fiscal deficit in check, there is scope for the RBI to do more to boost the economy,\" said Shilan Shah, deputy chief emerging markets economist at Capital Economics.</p>\n<p>\r\n\t\"This strengthens our conviction that the Bank - under new leadership - will begin easing monetary policy at the conclusion of its MPC meeting on Friday,\" he added.</p><div class=\"mb-20\"><div class=\"latestnews_stryalsoread__HlMna\"></div></div>\n<p>\r\n\tThe government said it is likely to post a full-year fiscal deficit of 4.8% of GDP in the current year ending March and expects to improve its finances, targeting a fiscal deficit of 4.4 per cent in 2025-26.</p><div id=\"between_article_content_3-0\" style=\"min-height:250px\"></div>\n<p>\r\n\tThe Indian economy is seen expanding by 6.3 per cent-6.8 per cent in the coming fiscal year after likely growing 6.4 per cent this year, its weakest in four years and sharply below the 8.2 per cent pace in fiscal 2024.</p>\n<p>\r\n\tDespite the slowdown in growth, inflation has stayed above the central bank's medium-term target of 4% for most of the past year, while the rupee has been steadily weakening, despite substantial dollar selling intervention from the RBI.</p>\n<p>\r\n\tWhile core inflation, seen as a better measure of demand driven price pressures, has been below 4 per cent, some economists believe the central bank may still need to focus on bringing down headline inflation.</p><div id=\"between_article_content_4-0\" style=\"min-height:250px\"></div>\n<p>\r\n\t\"With the budget ring-fencing growth risks, the monetary policy committee could concentrate on inflation management, while taking into account external spillovers,\" said Vivek Kumar, an economist with QuantEco Research who doesn't expect a cut on Friday but expects a total 50 bps easing in H1 FY26.</p>\n<p>\r\n\t\"The RBI, meanwhile, could enhance liquidity support further as the existing liquidity deficit dilutes the MPC's 'neutral' policy stance,\" he added.</p>\n<p>\r\n\tThe RBI announced a host of measures in late January which together would infuse Rs 1.5 trillion ($17.22 billion) into the banking system, but investors are hopeful of more steps including another a cash reserve ratio reduction on Friday. </p><div id=\"between_article_content_5-0\" style=\"min-height:250px\"></div>\n<p>\r\n\t </p><p></p></div>",
            "pub_date": "2025-02-04 16:20:33",
            "link": "https://www.business-standard.com/finance/news/rbi-seen-cutting-rates-for-first-time-since-may-2020-suggests-poll-125020400602_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400602"
        },
        {
            "title": "Nifty seen clearing first roadblock; next stop at 23,800? Key levels here",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div>The NSE Nifty 50 index has surged over 1 per cent in intra-day deals on Tuesday, and is now seen quoting above its super trend line on the daily scale for the first time since December 19, 2024. A close above 23,604, shall qualify as a positive breakout for the Nifty on the daily scale.<small class=\"brtagPara\"> </small> At the high point of the day so far, at 23,659, the Nifty gained 3.8 per cent from its recent low of 22,787. That apart, the Nifty 50 is seen quoting above its 20-DMA (Daily Moving Average) for the fourth straight trading session.<small class=\"brtagPara\"> </small> Technically, the Nifty is now seen clearing its first key hurdle as the index attempts a pullback from its record high of 26,277. The Nifty 50 had shed 13.3 per cent or almost 3,500 points from the peak in the last four months.<small class=\"brtagPara\"> </small> Amid the attempted recovery, the Nifty can potentially attempt a rebound towards 24,250 levels. The next key hurdle for the Nifty is placed around 23,780 levels, above which resistance can be expected around 24,020 and 24,150 levels. CLICK HERE FOR THE CHART<small class=\"brtagPara\"> </small> <strong>ALSO READ: <a href=\"https://www.business-standard.com/markets/news/nifty-may-target-24-300-post-budget-trump-tariff-rbi-policy-key-triggers-125020101053_1.html?1738656589\" target=\"_blank\">Nifty may target 24,300 post Budget; Trump tariff, RBI policy key triggers</a></strong><small class=\"brtagPara\"> </small> The near-term bias for the Nifty is likely to remain upbeat as long as the index holds above 23,500 levels; below which the key support for the index stands at the 20-DMA (Daily Moving Average) at 23,250.<small class=\"brtagPara\"> </small> The BSE Sensex, meanwhile, is seen quoting around 78,150 levels. The BSE benchmark has gained nearly 2,900 points from its recent low at 75,267.<small class=\"brtagPara\"> </small> The quarterly Fibonacci chart suggests that sustained trade above 78,150, shall pave the way for a likely rally towards 80,000-mark, above which a test of 81,150 seems likely. Interim resistance for the Sensex can be expected around 78,635 and 79,335 levels.  In case of a dip, the BSE Sensex may seek support around 77,500 levels.<small class=\"brtagPara\"> </small><br/></div>",
            "pub_date": "2025-02-04 16:20:32",
            "link": "https://www.business-standard.com/markets/news/nifty-seen-clearing-first-roadblock-next-stop-at-23-800-key-levels-here-125020400643_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400643"
        },
        {
            "title": "Upcoming IPO: Indogulf Cropsciences secures green light from Sebi; details",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><div>\r\n\tCrop protection products, plant nutrients, and biologicals manufacturing company Indogulf Cropsciences is all set to go public as the company has received final observation from the capital markets regulator, <a href=\"https://www.business-standard.com/about/what-is-sebi\" target=\"_blank\">Securities and Exchange Board of India (SEBI)</a>, to raise funds through an <a href=\"https://www.business-standard.com/about/what-is-ipo\" target=\"_blank\">initial public offering (IPO)</a>.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tIndogulf Cropsciences had filed its IPO papers with SEBI on September 25, 2024.</div>\n<small class=\"brtag\"> </small>\n<div>\n<a href=\"https://www.business-standard.com/markets/ipo/indogulf-cropsciences-ltd-ipo-89824\" target=\"_blank\">Indogulf Cropsciences IPO</a> comprises a fresh issue of up to Rs 200 crore, and an offer for sale (OFS) with shareholders divesting up to 38,54,840 equity shares of face value Rs 10 apiece. The OFS consists of up to 15,40,960 equity shares by Om Prakash Aggarwal (HUF) and up to 23,13,880 equity shares by Sanjay Aggarwal (HUF). \"The price band and the minimum bid lot will be decided by our company in consultation with the BRLM,\" Indogulf Cropsciences said in its DRHP.</div><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThe equity shares offered through the IPO are proposed to be listed on the BSE and NSE.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tBigshare Services serves as the registrar to the offer. Systematix Corporate Services is the sole book-running lead manager for the public offering.</div><div class=\"mb-20\"><div class=\"latestnews_stryalsoread__HlMna\"></div></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\t\"The company, in consultation with the book-running lead managers, may consider a pre-IPO placement of specified securities, which shall not exceed 20 per cent of the size of the fresh issue. If such a placement is completed, the fresh issue size will be reduced,\" said the company in its Draft Red Herring Prospectus (DRHP).</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThe company will not receive any proceeds from the OFS. According to the DRHP, the selling shareholders will be entitled to their respective portion of the proceeds from the Offer for Sale after deducting their proportion of offer expenses and relevant taxes thereon.</div><div id=\"between_article_content_3-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tIndogulf Cropsciences, however, intends to utilise the proceeds from the fresh issue for funding working capital requirements, and for repayment/prepayment, in full or in part, of certain outstanding borrowings availed by them. The company will further use the proceeds for capital expenditure, including setting up an in-house dry flowable (DF) plant at Barwasni, Sonipat, Haryana, as well as for general corporate purposes.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tIndogulf Cropsciences is engaged in the business of manufacturing crop protection products, plant nutrients, and biologicals in India. It is also one of the first indigenous manufacturers of Pyrazosulfuron Ethyl technical (Source: CareEdge Report), which commenced production in 2018. Indogulf Cropsciences began its operations in 1993 and primarily operates under three business verticals: crop protection, plant nutrients, and biologicals, catering to retail and institutional customers focused on improving crop yield.</div><div id=\"between_article_content_4-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small></div>",
            "pub_date": "2025-02-04 16:15:29",
            "link": "https://www.business-standard.com/markets/news/upcoming-ipo-indogulf-cropsciences-secures-green-light-from-sebi-details-125020400606_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400606"
        },
        {
            "title": "EC hits back at AAP: We are three-member body, not run by one person",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><p>\r\n\tAmid allegations levelled by the Aam Aadmi Party that the Election Commission is being run by CEC Rajiv Kumar, the poll panel on Tuesday hit back saying it is a three-member body which has collectively noted \"repeated deliberate pressure tactics\" to malign the poll authority in Delhi polls.</p>\n<p>\r\n\tIt said an impression is being created that the EC is a single member body.</p>\n<p>\r\n\tIn a post on X, the EC said it has decided to have constitutional restraint, absorbing such outbursts with sagacity, stoically and not to be swayed by such insinuations.<small class=\"brtag\"> </small></p>\n<div></div><div><blockquote class=\"twitter-tweet\">\n<p dir=\"ltr\" lang=\"en\">\r\n\t\tThe 3-member Commission collectively noted repeated deliberate pressure tactics to malign ECI in Delhi Elections,as if it is a single member body &amp; decided to have constitutional restraint, absorbing such outbursts with sagacity, stoically &amp; not to be swayed by such insinuations</p>\r\n\t— Election Commission of India (@ECISVEEP) <a href=\"https://twitter.com/ECISVEEP/status/1886668777791635682?ref_src=twsrc%5Etfw\" rel=\"nofollow\" target=\"_blank\">February 4, 2025</a></blockquote></div>\n<p>\r\n\tTop AAP leaders, including its convenor Arvind Karjiwal, have claimed that the EC has been ignoring the BJP's alleged violations of poll code.</p>\n<p>\r\n\tKejriwal had alleged that Kumar is not taking action against the BJP to bag a post-retirement assignment.</p>\n<p>\r\n\tKumar demits office on February 18 on attaining the age of 65 years.</p>\n<p>\r\n\tGyanesh Kumar and Sukhbir Singh Sandhu are the other election commissioners.</p>\n<p>\r\n\t\"The 3-member Commission collectively noted repeated deliberate pressure tactics to malign ECI in Delhi Elections,as if it is a single member body &amp; decided to have constitutional restraint, absorbing such outbursts with sagacity, stoically &amp; not to be swayed by such insinuations,\" the poll authority said in a rare reaction.</p>\n<p>\r\n\tDelhi goes to polls on Wednesday where AAP seeks to retain power and BJP trying to form the next government.</p></div>",
            "pub_date": "2025-02-04 16:15:28",
            "link": "https://www.business-standard.com/elections/delhi-elections/ec-hits-back-at-aap-we-are-three-member-body-not-run-by-one-person-125020400593_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400593"
        },
        {
            "title": "HFCL shares down 3% after posting Q3 results; PAT down 10%; revenue 2%",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><div>\r\n\tHFCL shares slipped 3.2 per cent on Tuesday, logging an intraday low at Rs 98.25 per share on BSE. The selling pressure in the stock came after the company posted its Q3 results.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tAround 12:59 PM, HFCL share price was down 1.51 per cent at Rs 100.01 per share on BSE. In comparison, the BSE Sensex was up 1.17 per cent at 78,091.81. The market capitalisation of the company stood at Rs 14,501.75 crore. The 52-week high of the stock was at Rs 171 per share and the 52-week low was at Rs 81.25 per share. </div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThe company released its Q3 results on Monday after market hours. HFCL reported 10 per cent decline in net profit to Rs 74 crore as compared to Rs 82.24 crore a year ago. The company's revenue for the quarter under review declined 2 per cent at Rs 1,011.95 crore as compared to Rs 1,032.31 crore a year ago. <small class=\"brtagPara\"> </small>\n<div>\n<strong class=\"read_more\">ALSO READ: <a href=\"https://www.business-standard.com/companies/results/hfcl-q3-results-pat-dips-11-95-to-rs-72-58-cr-revenue-at-rs-1-011-95-cr-125020301194_1.html\" target=\"_blank\">HFCL Q3 results: PAT dips 11.95% to Rs 72.58 cr, revenue at Rs 1,011.95 cr</a></strong></div></div><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\t\"Despite a dynamic and challenging market environment, HFCL has demonstrated resilience with a stable quarterly performance. Our unwavering commitment to innovation and strategic growth continues to drive us forward. The recent BharatNet order wins are a testament to our expertise in strengthening India’s digital infrastructure, reinforcing our position as a trusted technology partner in the Country’s broadband revolution\" said Mahendra Nahata, managing director, HFCL.</div><div class=\"mb-20\"><div class=\"latestnews_stryalsoread__HlMna\"></div></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tNahata added: As we move ahead, HFCL remains focused on expanding its technological capabilities, fostering innovation, and delivering value to our stakeholders. We are confident that our strategic initiatives will create long-term sustainable growth and strengthen our leadership in the industry.</div><div id=\"between_article_content_3-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tHFCL is a technology company specialising in creating digital networks for telcos, enterprises, and governments. Over the years, HFCL has emerged as a trusted partner offering sustainable high tech solutions with a commitment to provide the latest technology products to its customers. The company’s in-house reserach and development (R&amp;D) centers located at Gurgaon, Bengaluru and Hyderabad along with invested R&amp;D houses and other R&amp;D collaborators at different locations in India and abroad, innovate a futuristic range of technology products and solutions. </div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tIn the past one year, HFCL shares have gained 3.3 per cent against Sensex's rise of 7.6 per cent. </div><div id=\"between_article_content_4-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small></div>",
            "pub_date": "2025-02-04 16:10:28",
            "link": "https://www.business-standard.com/markets/news/hfcl-shares-down-3-after-company-posts-q3-results-pat-down-125020400638_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400638"
        },
        {
            "title": "Subhash Ghai buys Rs 24 cr flat in same building as Sonakshi Sinha's sale",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><div>\r\n\tBollywood director Subhash Ghai along with his wife Mukta Ghai has bought an apartment in Bandra West, Mumbai, for Rs 24 crore, according to property registration documents reviewed by Square Yards on the website of Inspector General of Registration (IGR) https://igrmaharashtra.gov.in. The transaction was registered in February 2025.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThe property bought by Ghai along with his wife is located in 81 Aureate, a project by MJ Shah Group, spread across 4.48 acres and featuring 4 BHK apartments. As per the IGR property registration documents reviewed by Square Yards, the apartment has a carpet area of 4,364 sq. ft. (405.42 sq. m.) and a built-up area of 486.69 sq. m. (~5,239 sq. ft.). It also includes three car parking spaces. The transaction incurred a stamp duty payment of Rs 1.44 crore and registration charges of Rs 30,000.</div><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tIn January, actress Sonakshi Sinha sold her apartment in the same project for Rs 22.5 crore, noted Square Yards. As per the registration documents, the actress brought this apartment in March 2020 for around Rs 14 crore and sold it in January this year for Rs 22.50 crore. With this, Sinha earned a profit of around 61 per cent after the deal was finalised. According to the IGR documents reviewed by Square Yards, the apartment features a carpet area of 391.2 sq. m. (approximately 4,211 sq. ft.) and a built-up area of 430.32 sq. m. (around 4,632 sq. ft.), along with three designated parking spaces. The transaction involved a stamp duty of Rs 1.35 crore and registration fees of Rs 30,000.  Notably, Sinha owns one more apartment in 81 Aureate, as per IGR property registration records.</div><div id=\"between_article_content_3-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tAccording to Square Yards Project Data Intelligence, eight transactions amounting to a gross transaction value of Rs 76 crore were registered with IGR in 81 Aureate between February 2024 and January 2025. Currently, the average resale property price for a 4BHK in the project stands at Rs 51,636 per sq.ft. while the average monthly asking rent is Rs 8.5 lakh.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tBandra’s proximity to Bandra Kurla Complex (BKC), Mumbai’s key commercial hub, makes it an attractive residential option for corporate executives and business owners seeking minimal commute times. Connectivity is a major advantage, with the Western Express Highway, Bandra-Worli Sea Link, international airport, and the upcoming metro enhancing accessibility. Bollywood stars such as Suniel Shetty, Ranveer Singh, and Deepika Padukone, Sonakshi Sinha along with sports personalities like KL Rahul and Athiya Shetty, also own properties in this neighbourhood.</div><div id=\"between_article_content_4-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tSubhash Ghai is an Indian film director, producer, actor, lyricist, music director, and screenwriter known for his work in Hindi cinema. He has directed and produced several films across different genres. His notable works include Kalicharan (1976), Vishwanath (1978), Karz (1980), Hero (1983), Vidhaata (1982), Meri Jung (1985), Karma (1986), Ram Lakhan (1989), Saudagar (1991), Khalnayak (1993), Pardes (1997), and Taal (1999). His films are known for their storytelling, music, and character-driven narratives.</div></div>",
            "pub_date": "2025-02-04 16:10:28",
            "link": "https://www.business-standard.com/finance/personal-finance/bollywood-director-subhash-ghai-wife-buy-rs-24-crore-flat-in-bandra-west-125020400626_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400626"
        },
        {
            "title": "Mobikwik shares slip 5% after company posts net loss against profit YoY",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><div>\r\n\tMobikwik shares slumped 3.2 per cent on Tuesday, logging an intraday low at Rs 385.65 per share on BSE. The selling pressure in the stock came after the company posted its <a href=\"https://www.business-standard.com/topic/q3-results\" target=\"_blank\">Q3 results</a>.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tAround 1:11 PM, <a href=\"https://www.business-standard.com/markets/one-mobikwik-systems-ltd-share-price-68099.html\" target=\"_blank\">Mobikwik share price</a> was down 1.49 per cent at Rs 400.2 per share on BSE. In comparison, the BSE Sensex was up 1.17 per cent at 78,091.81. The market capitalisation of the company stood at Rs 3,109.01 crore. The 52-week high of the stock was at Rs 698.3 per share and the 52-week low was at Rs 366.85 per share. </div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThe company released its Q3 results on Tuesday during market hours. The company reported a consolidated net loss to Rs 55.28 crore as compared to a profit of Rs 5.27 crore a year ago. Mobikwik's revenue for the quarter under review rose 17.7 per cent at Rs 269.47 crore as compared to Rs 228.93 crore a year ago. <small class=\"brtagPara\"> </small>\n<div>\n<strong class=\"read_more\">ALSO READ: <a href=\"https://www.business-standard.com/companies/results/mobikwik-posts-rs-3-59-crore-loss-in-q2fy25-total-income-grows-42-125010700679_1.html\" target=\"_blank\">MobiKwik posts Rs 3.59 crore loss in Q2FY25, total income grows 42%</a></strong></div></div><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tIn the previous quarter (Q2), the fintech firm reported a consolidated net loss of Rs 3.59 crore in the July-September quarter of the financial year 2024-2025 (FY25). The Gurugram-based company’s total income rose 42 per cent on a year-on-year (Y-o-Y) basis to Rs 293.66 crore in Q2FY25 from Rs 206.83 crore in Q2FY24. </div><div class=\"mb-20\"><div class=\"latestnews_stryalsoread__HlMna\"></div></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tShares of One Mobikwik Systems made a stellar debut on bourses on December 18, 2024, with a 58.51 per cent premium over the IPO allotment price of Rs 279 on BSE at Rs 442.25 apiece. <small class=\"brtagPara\"> </small>\n<div>\n<strong class=\"read_more\">ALSO READ: <a href=\"https://www.business-standard.com/markets/news/mobikwik-shares-list-at-58-premium-on-bse-nse-follow-ipo-gmp-trend-124121800233_1.html\" target=\"_blank\">Mobikwik shares list at 58% premium on BSE, NSE; follow IPO GMP trend</a></strong></div></div><div id=\"between_article_content_3-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tOn the National Stock Exchange (NSE), Mobikwik shares were listed at Rs 440, reflecting a premium of 57.7 per cent per share against the issue price. Currently, the stock trading at Rs 572.85 per share has gained over 120 per cent from its issue price. <small class=\"brtagPara\"> </small>\n<div>\n<strong class=\"read_more\">ALSO READ: <a href=\"https://www.business-standard.com/markets/news/mobikwik-q3-results-should-you-buy-stock-ahead-of-nos-what-analysts-say-125010600290_1.html\" target=\"_blank\">Mobikwik Q2 results: Should you buy stock ahead of nos? What analysts say</a></strong></div>\n</div>\n<small class=\"brtag\"> </small></div>",
            "pub_date": "2025-02-04 16:05:26",
            "link": "https://www.business-standard.com/markets/news/mobikwik-shares-slip-5-after-company-posts-net-loss-against-profit-yoy-125020400621_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400621"
        },
        {
            "title": "Eris Lifesciences shares drop 5% after profit slides in Q3 results; details",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><div>\r\n\tEris Lifesciences share price slipped 5.35 per cent at Rs 1,181.20 a piece on the BSE in Tuesday’s intraday trade after the company’s net profit dropped in the third quarter of the financial year 2024-25 (Q3FY25).</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThe company’s net profit came in at Rs 87 crore, down 14.3 per cent year-on-year (Y-o-Y), compared to Rs 101 crore in the same quarter last year. <small class=\"brtag\"> </small></div>\n<div>\r\n\tMeanwhile, the revenue from operations surged 35 per cent Y-o-Y to Rs 635 crore, compared to Rs 471 crore in Q3FY24. For the first nine months of FY25 (9MFY25), revenue stood at Rs 1,911 crore, a 35 per cent Y-o-Y growth over Rs 1,418 crore in 9MFY24.</div><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<div>\n<small class=\"brtagPara\"> </small>\r\n\tEarnings before interest, tax, depreciation and amortisation (Ebitda) witnessed a robust increase, reaching Rs 230 crore in Q3FY25, reflecting a 31 per cent growth from Rs 174 crore in Q3FY24. On a 9M basis, Ebitda grew 36 per cent Y-o-Y to Rs 695 crore, up from Rs 524 crore in 9MFY24.<small class=\"brtag\"> </small></div>\n<div>\r\n\tEbitda Margin dropped to 36.2 per cent in Q3FY25, compared to 37.0 per cent in Q3FY24, while for 9M FY25, the margin came in at 36.4 per cent, slightly lower than 36.9 per cent in 9MFY24.<small class=\"brtag\"> </small></div><div class=\"mb-20\"><div class=\"latestnews_stryalsoread__HlMna\"></div></div>\n<div>\r\n\tOn the equities front, Eris Lifesciences share price has risen 6.6 per cent in the last six months, while gaining 34.3 per cent in the last one year. In comparison, the BSE Sensex has slipped 3.4 per cent in the last six months, while rising 8.4 per cent in the last one year. <small class=\"brtag\"> </small></div><div id=\"between_article_content_3-0\" style=\"min-height:250px\"></div>\n<div>\r\n\tEris Lifesciences has a total market capitalisation of Rs 16,281.74  crore. Its shares are listed at a price to earnings multiple of 146.07 and at an earning per share of Rs 8.54, according to BSE.  </div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tAt 1:28 PM, the stock price of the company was down 4.16 per cent at Rs 1196.05 a piece on the BSE. By comparison, the BSE’s Sensex was up 1.27 per cent to 78,168.23 level.</div>\n<small class=\"brtag\"> </small></div>",
            "pub_date": "2025-02-04 16:05:25",
            "link": "https://www.business-standard.com/markets/news/eris-lifesciences-shares-drop-5-after-profit-slides-in-q3-results-details-125020400627_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400627"
        }
    ]
}